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activation
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Abstract
Background: Phenoloxidase (PO)-catalyzed melanization is a universal defense mechanism of insects against
pathogenic and parasitic infections. In mosquitos such as Anopheles gambiae, melanotic encapsulation is a resistance
mechanism against certain parasites that cause malaria and filariasis. PO is initially synthesized by hemocytes and
released into hemolymph as inactive prophenoloxidase (PPO), which is activated by a serine protease cascade upon
recognition of foreign invaders. The mechanisms of PPO activation and PO catalysis have been elusive.
Results: Herein, we report the crystal structure of PPO8 from A. gambiae at 2.6 Å resolution. PPO8 forms a homodimer
with each subunit displaying a classical type III di-copper active center. Our molecular docking and mutagenesis
studies revealed a new substrate-binding site with Glu364 as the catalytic residue responsible for the deprotonation of
mono- and di-phenolic substrates. Mutation of Glu364 severely impaired both the monophenol hydroxylase and
diphenoloxidase activities of AgPPO8. Our data suggested that the newly identified substrate-binding pocket is the
actual site for catalysis, and PPO activation could be achieved without withdrawing the conserved phenylalanine
residue that was previously deemed as the substrate ‘placeholder’.
Conclusions: We present the structural and functional data from a mosquito PPO. Our results revealed a novel
substrate-binding site with Glu364 identified as the key catalytic residue for PO enzymatic activities. Our data offered a
new model for PPO activation at the molecular level, which differs from the canonical mechanism that demands
withdrawing a blocking phenylalanine residue from the previously deemed substrate-binding site. This study provides
new insights into the mechanisms of PPO activation and enzymatic catalysis of PO.
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Background
Phenoloxidase (PO) is a critical enzyme involved in mul-
tiple physiological processes including innate immunity
of insects and crustaceans. As the close homolog of
arthropod hemocyanins, PO is produced in hemocytes
as a zymogen, the prophenoloxidase (PPO) [1]. Upon
pathogenic infections or physical injuries, a serine protease
cascade is triggered to activate PPO as a local response.
The last step of PPO activation involves a trypsin-like
enzyme, named PPO-activating proteinase (PAP), which
cleaves PPO at a conserved proteolytic cleavage site near
the N-terminus to generate active PO [2, 3]. In vitro, PPO
can also be activated without proteolytic cleavage by certain
chemicals such as ethanol or detergents (e.g. cetylpyridi-
nium chloride, CPC) [4–6].
In general, the active PO possesses o-hydroxylase (EC
1.14.18.1) and o-diphenoloxidase (EC 1.10.3.1) activities
that convert a variety of monophenolic and o-diphenolic
substrates to o-quinones [6, 7]. Quinones may act as
cross-linkers for wound healing, and they also
polymerize to form melanin capsules around parasites
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and parasitoids [7, 8]. Quinones and other reactive inter-
mediates (e.g. 5,6-dihydroxyindole) directly kill microbial
pathogens and parasitoids [9].
POs, together with hemocyanins, tyrosinases, and cat-
echol oxidases, belong to the type III di-copper family of
proteins, which share an antiferromagnetically coupled di-
copper center [10, 11]. This group of proteins are widely
distributed in different organisms: POs in arthropods,
tyrosinases in microbes, plants and mammals, catechol
oxidases in plants and fungi, and hemocyanins in arthro-
pods and molluscs [12–14]. Tyrosinases and catechol oxi-
dases are responsible for browning of fruits and plants,
and they may also play a role in defense mechanism in
plants and fungi [15]. Mammalian tyrosinase is a major
enzyme required for coloring of hair, skin and eyes, and
its deficiency and excessive expression could lead to albin-
ism and skin cancer, respectively [7, 16, 17]. Hemocyanins
were initially recognized as oxygen carriers in hemolymph
[18], but their PO activities and roles in antimicrobial
defense were discovered later [6, 19]. In spite of having a
similar active site, vital structural and functional differ-
ences do exist in these proteins as has been demonstrated
in the past decades. Tyrosinases and POs catalyze both
the o-hydroxylation and oxidation reactions, but catechol
oxidases only possess the oxidase activity [20, 21]. Based
on their similarities in the primary and tertiary structures,
POs were considered to be evolutionarily more related to
arthropod hemocyanins, whereas tyrosinases and catechol
oxidases are closer to molluscan hemocyanins [19, 22, 23].
In the catalytic cycle, type III di-copper center goes
through three redox states: the reduced deoxy state
[Cu(I)-Cu(I)], the oxy state [Cu(II)-O2
2−-Cu(II)] in
which a peroxide molecule binds to the two Cu ions in
a μ-η2:η2 side-on bridging fashion, and the met state
[Cu(II)-OH−-Cu(II)] in which the two Cu ions are
ligated to a hydroxide ion [10]. The oxy state enzyme is
capable of catalyzing both the hydroxylation of mono-
phenols and the oxidation of o-diphenols to o-qui-
nones, while the met state only undertakes the latter
diphenol oxidase reaction [10].
PO catalyzed-melanogenesis is indispensable in the
immune system of invertebrates [24, 25] and two PPO
structures from Manduca sexta and Marsupenaeus japo-
nicus have been investigated [26, 27]. Although these
studies on PPO provided important structural and func-
tional insights, the detailed enzymatic mechanism of PO
is still undetermined and the fundamentals of PPO acti-
vation remain elusive. A. gambiae is a major vector of
human malaria parasites in Africa, whose innate im-
mune system protects the mosquito from infection by
incompatible malaria parasites [28]. It contains nine
PPO genes which are expressed at different tissues and
life stages [29–32]. Herein, we report the crystal struc-
ture of AgPPO8 at 2.6 Å resolution, representing the
first structure from a recombinant PPO and the first
from a mosquito species. Our structural and functional
studies on AgPPO8 revealed a novel substrate-binding
pocket that differs from the previously deemed ‘place-
holder’ position occupied by a phenylalanine residue,
which is conserved in PPOs, but not in molluscan
hemocyanins, tyrosinases, or catechol oxidases. We
identified E364 as a catalytic residue key to the PO activ-
ities. Our data provide new insights into the mechanism
of PO catalysis, which could be applicable to other type
III di-copper proteins, and suggest a new model for PPO
activation at the molecular level.
Results
Overall structure of AgPPO8
The crystal structure of AgPPO8 contains two identical
subunits, each comprising 700 residues, which are asso-
ciated tightly to form a homodimer in the asymmetric
unit. The overall structure of the AgPPO8 displays a
butterfly shape of 147 × 70 × 60 Å in size (Fig. 1a). Most
residues are well defined, except for 40 amino acids that
lack electron densities. These include residues 59–65,
580–587, 629–632, and 698–700 in chain A and residues
1, 2, 65–68, 579–587, and 698–700 in chain B. AgPPO8
adopts a similar architecture as that of M. sexta PPO
(MsPPO) [26], with the three conserved domains
(Fig. 1b). The pro-region (17–81) contains the conserved
proteolytic cleavage site (R51*F52). Domain I (1–16,
82–196) is dominant in α-helices. Domain II (197–435)
contains the di-copper active site buried in an α-helix
bundle. Domain III (436–697) is mainly a seven-
stranded β barrel, with an additional β-hairpin extended
to domains I and II. There are two disulfide bonds
(C592-C636 and C594-C643) within domain III of each
subunit, which are highly conserved among hemocya-
nins and PPOs. C592-C636 is situated on the surface
and exposed to the solvent, while C594-C643 is located
at the interface of domains II and III, which may con-
tribute to the structural stability. The overall structure
of AgPPO8 homodimer closely resembles that of
MsPPO heterodimer (Fig. 1c), with a 1.14 Å root-
mean-square deviation over 1,129 aligned Cα atoms.
Dimerization of AgPPO8
AgPPO8 was found to stay mainly as a homodimer in
solution by size exclusion chromatography and dynamic
light scattering (Additional file 1). Two types of
dimerization patterns exist in the crystal structure, a tight
homodimer and a loose one. The tight dimer associates
(chain A and chain B) via a two-fold non-crystallographic
symmetry axis in the asymmetric unit. The loose dimer
involves chain A molecule and a crystallographic
symmetry-related chain B molecule in the crystal lattice.
The tight dimer interface is mainly stabilized through
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extensive hydrophobic and charge-charge interactions
predominantly from domains I and II, burying a large
(4,624 Å solvent accessible surface area which is com-
parable to that of MsPPO heterodimer [26]. In contrast,
the loose dimer buries a much smaller surface area (
934 Å2) at the interface. The tight homo-dimeric asso-
ciation of AgPPO8 was also confirmed with an analysis
performed with the PISA server (http://www.ebi.ac.uk/
msd-srv/prot_int/pistart.html), suggesting it is the bio-
logically functional dimer.
Active site of AgPPO8
During refinement, we observed a large positive difference
electron density at the supposed bi-metal center (Add-
itional file 2), although no additional metal ions were sup-
plied during the protein expression. We believe the bound
metal ions came from the trace amount of metal in LB
medium. The identities of the metal consequently could
not be unambiguously determined in this study, since
either Zn or Cu atoms could be positioned at the same
locations and refine well. This observation is consistent
with a previous report that heterogeneous incorporation
of zinc and copper ions was found at the active site of Ba-
cillus megaterium tyrosinase [33]. In this study, we inter-
preted the metals as Cu ions and finalized that in the
deposited structure. Each metal ion is coordinated with
the NE2 atoms of three histidine residues, which are
highly conserved in this protein family (Fig. 1d): CuA is
associated with H223, H227 and H252, while CuB is asso-
ciated with H379, H383 and H419. All six histidine resi-
dues are located in the α-helix bundle from domain II,
and stabilized by three Phe residues (F99, F248 and F415)
through hydrophobic interactions: F99 with H379 and
H383, F248 with H227, H252 and H379, and F415 with
H223, H252, H383 and H419 (Additional file 3). The dis-
tance between the two copper atoms is 4.5 Å, which is
the typical distance for the reduced form of type III di-
copper proteins. The UV/Vis absorption spectrum did
not exhibit any apparent characteristic feature from 250
to 700 nm (Additional file 4), supporting that the
AgPPO8 structure we obtained was in the deoxy state.
The di-copper center observed in AgPPO8 is similar
to those in other type III copper enzymes. However, the
catalytic residue has been elusive due to the amino acid
Fig. 1 Crystal structure of A. gambiae PPO8. (a) Overall structure of the homodimer with each subunit shown in cyan and green, respectively.
Cu atoms are shown as brown spheres. (b) The domain structure of AgPPO8: pro-region, magenta; domain I, blue; domain II, yellow; domain III, green.
The Cu atoms are shown as brown spheres and the disulfide bonds are shown as red sticks. The side chain of Arg51 preceding the proteolytic
cleavage site is shown as a black stick. (c) Superposition of AgPPO8 (cyan) with M. sexta PPO heterodimer (PPO-1 in magenta and 2 in yellow, PDB ID
3HHS). AgPPO8 is 41.1 % identical in a.a. sequence to MsPPO1 and 38.8 % to MsPPO2. (d) The di-copper active site of A. gambiae PPO8. The Cu atoms
are shown as brown spheres. Six conserved His residues (magenta) coordinate CuA and CuB, and are stabilized by three Phe residues (F248, F415 and
the 'placeholder' F99, shown as red sticks). V406 (orange) aligns to a putative catalytic residue E395 in MsPPO2. Glu364 (green) forms a salt bridge (black
dash) with R244 (yellow), and is required for the enzymatic activities of AgPPO8. The secondary structures of AgPPO8 are shown and colored in cyan
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variations near the dicopper center (Fig. 2). In MsPPO2,
one unique acidic residue (E395) was proposed to be a
catalytic residue responsible for the hydroxylase activity
of the enzyme since its carboxylic oxygen in the side
chain may deprotonate the hydroxyl group of the mono-
phenol substrate (Fig. 2c) [26, 34]. Remarkably, although
AgPPO8 was able to convert monophenol to diphenol
(see below), it contains a valine residue (V406) at the
equivalent position, which lacks an acidic side chain
(Fig. 1d, 2a). Therefore, the deprotonation of the phen-
olic substrate during AgPPO8 enzymatic catalysis may
involve a different residue.
Substrate binding by AgPPO8
As seen in other arthropod PPOs and hemocyanins,
AgPPO8 also contains a putative ‘placeholder’ for phenolic
substrates, which is F99 in each subunit (Fig. 1d, Additional
file 3). This conserved residue resides in a loop of domain I
Fig. 2 Comparison of the di-copper centers from different type III copper proteins. (a) A. gambiae PPO8 (AgPPO8), PDB ID 4YZW; (b) M. sexta
PPO1 (MsPPO1), 3HHS-B; (c) M. sexta PPO2 (MsPPO2), 3HHS-A; (d) Marsupenaeus japonicus (Mj) PPOβ, 3WKY; (e) Limulus polyphemus hemocyanin
deoxy state (LpHc), 1LLA; (f) Octopus hemocyanin functional unit Odg, 1JS8; (g) Ipomoea batatas catechol oxidase (IbCO) in complex with
1-phenyl-2-thiourea (PTU), 1BUG; (h) Vitis vinifera catechol oxidase (VvCO), 2P3X; (i) Streptomyces castaneoglobisporus tyrosinase (ScTyr),
2ZMX; (j) Agaricus bisporus tyrosinase (AbTyr), 2Y9W; (k) Aspergillus oryzae pro-tyrosinase (AoProTyr), 3W6W; (l) Superposition of BmTyr structures in
complex with bound tyrosine (4P6R) and L-DOPA (4P6S) (BmTyr:T/D); (m) Superposition of the active sites from AgPPO8, ScTyr, AoProTyr, LpHc and
BmTyr:D. Space overlapping between the placeholders and phenolic substrate is indicated by a red dashed cycle. The Cu or Zn atoms are shown as
large brown or gray spheres, the Cu-coordinated or hydrogen-bonded water molecules are shown as small red spheres. The hydrogen bonds are indi-
cated as black dashes
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with its aromatic side chain protruding to the di-copper
center and stacking onto the imidazole ring of H383 at the
CuB site. It was assumed in the prior studies that the place-
holder aromatic residue would be withdrawn from the di-
copper center during PPO activation through major con-
formational changes (see discussion), allowing its position
be replaced by a natural phenolic substrate during enzym-
atic catalysis. Interestingly, the analysis of the AgPPO8
structure revealed a prominent cavity in the di-copper
reaction center, which is close (~1.5 Å) to the solvent-
accessible surface (Fig. 3a). This cavity is surrounded by
the six Cu-coordinating His residues, F99, F415, E364,
N380, V406, along with other residues from domain I and
II (Fig. 3a). The volume of the cavity (451 Å3, calculated
by program CASTp [35]) appears large enough to ac-
commodate monophenolic or diphenolic substrates such
as tyramine and dopamine (approximately 190–200 Å3).
Therefore, we named this pocket as the second substrate-
binding site (Site II) with respect to the placeholder pos-
ition (Site I). To test if this pocket could hold substrates,
we carried out docking experiments using the Autodock
program. After selecting certain amino acids at the active
site as the flexible residues to accommodate potential pro-
tein dynamics (see Methods), we individually docked tyr-
amine and dopamine into AgPPO8 (Additional file 5).
Although a larger grid box covering the entire di-copper
center and the empty cavity was set as the search space,
both substrates were successfully docked into the putative
substrate-binding Site II in similar orientations (Fig. 3b)
without significant reconfiguration of the active site
(Fig. 3c,d). This observation suggested substrate binding
to PPO could be achieved without displacing the place-
holder. Interestingly, in the docked protein structures, we
found residue E364 located very close to the docked sub-
strates (Fig. 3c,d). Albeit distant from the di-copper center
(6.7 and 7.6 Å from CuA and CuB in apo-AgPPO8), the
Fig. 3 A new and unique substrate-binding pocket (Site II) of AgPPO8. (a) AgPPO8 contains a cavity approximate to surface (Site II, side view).
The cavity and solvent exposed surface areas are represented in cyan and gray, respectively. The key residues surrounding the cavity are shown
as violet sticks. (b) The side view of Site II pocket with tyramine (green) and dopamine (yellow) docked inside. The distances (Å) from the phenolic
oxygens of the substrates to CuA and CuB are indicated. (c and d) Superposition of the active sites before and after docking. The active site residues of
the apo-AgPPO8 are shown as magenta sticks, while the complex structures with docked substrates bound are colored in cyan (tyramine) and green
(dopamine), respectively. The hydrogen bonding between the substrate and E364 is highlighted with black dash. The distances (Å) from E364 to CuA,
CuB, the putative placeholder F99, and the phenolic oxygens of docked substrates (yellow sticks) are indicated. The distance of the salt bridge between
residues E364 and R244 is also labeled (before docking, magenta; after docking, tyramine, cyan and dopamine, green). CuA and CuB are shown as
brown spheres
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OE2 atom of E364 is 3.0 and 3.1 Å to the phenolic oxygens
of tyramine and dopamine, respectively. This observation
suggested that E364 could play an important role in the
deprotonation of the phenolic substrates, which was shown
to be essential for binding of the phenolic oxygen to one of
the copper atoms [34, 36, 37]. E364 also forms a salt bridge
with R244 in a stable conformation, which may assist in
correctly positioning the carboxylic side chain during the
deprotonation process (Figs. 1d and 3c,d). We found this
Glu residue highly conserved among other type III di-
copper proteins (Fig. 2). These observations indicated that
this Glu residue could be a common catalytic residue for
PO enzymatic activities, and may serve in an alternative
mechanism for PPO activation (see below).
E364 is key to hydroxylation and oxidation
To test our hypothesis that E364 is essential for the en-
zymatic activities of AgPPO8 by deprotonating phenolic
substrates, we mutated it to a neutral Gln residue. The
recombinant E364Q mutant was expressed as a soluble
protein in E. coli cells and folded properly with an ap-
proaching melting point as the wild type as shown from
the Differential Scanning Fluorimetry analysis (Add-
itional file 6). The enzymatic activities of both wild type
and mutant AgPPO8 were assayed in vitro. When using
dopamine as the substrate, the E364Q mutant lost nearly
89 % of its oxidase activity compared to the wild type
(Fig. 4a), indicating E364 is the base responsible for the
deprotonation of diphenolic substrate. When using tyr-
amine as the substrate, E364Q mutant impaired 93 % of
its hydroxylase activity compared to the wild type
(Fig. 4b), by detecting the dopamine formation at
280 nm. This demonstrated that E364 is also necessary
for deprotonating the monophenolic substrate. Taken
together, we conclude that E364 is essential for both
the hydroxylase and oxidase activities of AgPPO8 with
its carboxylate group acting as a general base for mono-
phenol and diphenol deprotonation.
Discussion
In this study, we determined the crystal structure of
AgPPO8, which is the first structure of recombinant PPO
and the first from a mosquito species. The structural and
functional studies on AgPPO8 revealed a novel substrate-
binding pocket and identified E364 as a catalytic residue
key to the PO activities. Our data also provide new
insights into the catalytic mechanism of PO and suggest a
new model for PPO activation at the molecular level.
Catalytic residues for phenol deprotonation
Enzymatic activities of type III copper protein require
deprotonation of the phenolic substrates, which is essen-
tial for coordinating the phenolic oxygen to one of the
copper atoms and subsequent catalytic reactions [34, 36,
37]. So far, at least five different residues have been pro-
posed as the potential deprotonating base. In Streptomyces
castaneoglobisporus tyrosinase (ScTyr), a flexible, CuA-
coordinating H54 was supposed to serve as the base [38].
This is not applicable to PPOs due to inflexibility of their
His residues in the active site [26]. In mouse tyrosinase, a
free His preceding the sixth coordinating His is vital for
the oxidation of diphenols [39], yet this residue is absent
in arthropod hemocyanins and PPOs. In MsPPO2, there
are two acidic Glu residues in the vicinity of its binuclear
Fig. 4 E364 is key to PO enzymatic catalysis. (a) E364Q mutation severely impairs diphenol oxidase activity of AgPPO8. Dopamine was used as
the substrate and specific PO activity was shown as ΔmOD470/min/μg or U/μg; P <0.001. (b) E364Q mutation severely impairs the monophenol
hydroxylase activity of AgPPO8. Tyramine was used as the substrate and the rate of dopamine formation catalyzed by 1 μg enzyme was
estimated as ΔmOD280/min/μg or U/μg; P <0.001. All data were presented as mean ± SEM (n = 3)
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center, E353 (equivalent to E364 of AgPPO8) and E395
[26]. Since E395 is located much closer to CuA, the
presumed site for hydroxylase activity [40, 41], and
within 3 Å distance from residue F88, the ‘placeholder’
for phenolic substrates, it was postulated to be respon-
sible for tyrosine deprotonation in the monooxygenase
reaction. However, this Glu residue is not present in
most type III di-copper proteins that exhibit the hy-
droxylase activity (Fig. 2). Due to technical difficulties
in expressing recombinant MsPPOs, the putative cata-
lytic function of E395 in MsPPO2 has not been verified
experimentally through mutagenesis analysis. Recent
studies on B. megaterium tyrosinase provided complex
structures in met form with bound tyrosine or L-DOPA
(BmTyr:T/D), revealing that the CuA site is solely re-
sponsible for its monooxygenase and diphenoloxidase
activities [42]. A conserved water molecule activated by
E195 was proposed to be the intermediate base for
deprotonating the entering substrates, since it is closer
to the di-copper center than the candidate residue E195
(Fig. 2l). Nevertheless, the water molecule was not
observed to have direct contact with the bound sub-
strates in the met form structures. In AgPPO8, E364 is
the equivalent residue to BmTyr E195. The proposed
catalytic water molecule also exists in the current struc-
ture, which is situated at a 6 Å distance from CuA and
stabilized by E364 and N380 (Fig. 2a). It may be pos-
sible that AgPPO8 also adopts a similar water-mediated
deprotonation mechanism in its catalytic reaction.
However, the role of this water molecule has not been
confirmed since it is not found in the crystal structure
of Vitis vinifera catechol oxidase (VvCO) (Fig. 2h),
which contains the conserved E235 and N240 [43]. In
the structure of Ipomoea batatas catechol oxidase
(IbCO) (Fig. 2g), E236 was suggested to be responsible
for the deprotonation of diphenolic substrates [44].
This Glu also aligns to E364 of AgPPO8, which is in
fact highly conserved among type III di-copper proteins
(Fig. 2). Our functional study confirmed the importance
of E364 in both hydroxylase and oxidase activities of
AgPPO8, representing the crucial mutagenesis data for
PPO for the first time in the field. Collectively, these
lines of evidence suggest that the Glu residue at this
position is essential to type III copper enzyme activities
by playing a critical role in the deprotonation of phen-
olic substrates. E364 of AgPPO8 is 7 Å away from the
putative ‘placeholder’ F99 (Fig. 3d), making it unlikely
to deprotonate the phenolic substrate at Site I. In con-
trast, E364 is in proximity to the docked substrates in
the newly identified substrate-binding pocket Site II,
implying that Site II might be the actual substrate-
binding site for PO activities, at least for the initial sub-
strate binding, which is independent of the canonical
‘placeholder’ position.
The activation mechanism of PPOs: a loop gated entrance
for substrate
PPO is synthesized in hemocytes and released to plasma,
while partially transported to cuticles [45]. The activa-
tion of MsPPO requires the presence of PAP and SPHs
simultaneously [46]. Without the SPHs, PAP can cleave
PPO at the correct position but the product does not
display PO activities. It was hypothesized that PPO acti-
vation is carried out by a PAP on the surface of a large
complex of the SPHs [47]. In vitro, it was shown that
PPO could be alternatively activated by treatment of
detergents without proteolytic cleavage [4]. However, the
mechanism of PPO activation remains elusive at the
molecular level.
The di-copper active centers of all known type-3 cop-
per protein structures could be well superimposed
(Fig. 2). It was supposed that, in these structures, the
entrances to the di-copper center are blocked by hydro-
phobic residues that need to be dislodged for activation.
The blocker is a highly conserved Phe residue in all
known arthropod hemocyanins, and a less conserved ali-
phatic amino acid in mollusc hemocyanins [11, 19]. In
ScTyr, a caddie protein ORF378 acts as a shielding
domain with its Y98 inserted into the substrate-binding
pocket of tyrosinase [38]. This Tyr residue is kept away
from the active site by the caddie protein at a sufficient
distance to avoid reaction. The structure of Aspergillus
oryzae pro-tyrosinase (AoProTyr) also confirms that
F513 of C-terminal domain extends into the binuclear
active site, protecting the enzyme from early reaction
[48]. In the structure of IbCO, an inhibitor (1-phenyl-2-
thiourea) is located at the equivalent position [44].
Because the aromatic rings of these blocking residues
could be well superimposed to each other, they were
suggested as the placeholders for incoming substrates
and are stabilized by stacking interactions with a His
residue at the CuB site [40]. By overlaying the active
sites of these known type III protein structures onto the
BmTyr:T/D complex [42], space clashes between the
placeholders and phenolic substrates can be easily de-
tected (Fig. 2m). These data implied that the placeholder
must be removed to accommodate the substrate binding.
In arthropod PPOs, a conserved Phe residue from the
N-terminal domain I was considered as the substrate
placeholder [26, 27]. Therefore, dislocation of the place-
holder to make place for substrate access was assumed
as a necessary step for PPO activation.
Hemocyanins are generally functional as oxygen car-
riers, although they were shown to be able to get acti-
vated in vitro by certain detergents and chemicals in the
same way as PPOs [6, 19]. The conformational changes
of the placeholder Phe residue in certain hemocyanins
were observed. For example, the structural comparison
of L. polyphemus hemocyanin subunit II of oxygenated
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state with deoxygenated Panulirus interruptus
hemocyanin revealed an 8° rotation of domain I upon
oxygen binding, pulling the placeholder F49 away from
the active site [49, 50]. SDS activation of P. imperator
hemocyanin oligomer also twisted domain I away from
domains II and III, consequently removing F49 about
3.5 Å away from its original position [51].
The structure of AgPPO8 revealed an alternative
substrate-binding Site II. In our docking analysis of
AgPPO8, substrates could be accommodated in the
putative binding pocket Site II without displacing the
placeholder F99. This observation led to a reevaluation
of the activation mechanism of type III di-copper pro-
teins. There is a profound structural difference between
the proteolytic activation of PPOs and other precursors
of type III di-copper proteins. In pro-tyrosinases and
hemocyanins, the proteolysis removes the shielding
domain including the placeholder, exposing the catalytic
di-copper center for substrate binding [48, 52]. A similar
activation mechanism was also suggested for pro-catechol
oxidases [53], while in PPOs multiple cleavage sites have
been identified among different species [13, 46, 54–59]. In
most cases, the proteolytic cleavage of the N-terminal
fragment does not remove the placeholder, which remains
in the core of the enzyme downstream to the proteolytic
cleavage site [46, 57–59], and a subsequent conform-
ational change is required to induce the enzyme activity
since the active site is still buried. Indeed, the conserved
placeholder Phe residue of PPOs is involved in extensive
non-polar interactions with the Cu-coordinating His resi-
dues, stabilizing the active center. Dislodging the place-
holder in PPO would require major conformational
changes involving disruption of multiple domain–domain
interactions. Should this happen in vivo, it could possibly
be assisted by other protein complexes, which stabilize the
labile intermediate conformation. However, a smaller con-
formational change could be sufficient for substrate to
enter the active center via Site II (Fig. 5). The putative
substrate-binding pocket in AgPPO8 is close to the solv-
ent with the entrance gated by a flexible loop YPASGP
(230–235) from domain II and the α-helix P101-D116
from domain I at the molecular surface (Fig. 5a). The loop
contacts the α-helix merely via loose van der Waals inter-
actions, suggesting that reorientation of the loop by
modulating PPO surface plasticity is possible. The N-
terminal Tyr-Pro and C-terminal Gly-Pro of the loop,
which are highly conserved among different PPOs (Fig. 5a,
Inset), have a higher frequency of occurrences in cis-trans
conformational switching [60, 61], and may therefore
serve as the hinge facilitating the loop to flip over and
open up the gate towards Site II, allowing its access by the
substrates (Fig. 5b). This model apparently does not need
the withdrawal of the placeholder F99, which is buried in
the core of the protein. Notably, when we manually
removed the placeholder F99 from the structure of
AgPPO8 in the docking experiment, the phenolic sub-
strate still docked to Site II (Additional file 7), further sup-
porting its preferential binding of substrate. Taking into
account that the phenolic oxygen of the docked substrates
is 6.5–7.3 Å away from the di-nuclear coppers (Fig. 3b),
the orientation of docked substrates could represent the
initial substrate binding. Further shifting of the substrate
towards the di-copper center is required in order for the
catalysis to occur. In fact, there is extra vacant space
within the Site II pocket immediately above the di-copper
center (Fig. 3b). Therefore, subsequent fine-tuning of the
active site geometry could be sufficient for coordinating
the bound substrate to the di-copper atoms within Site II
pocket.
Our data here suggested an alternative model for PPO
activation without displacing the canonical ‘placeholder’
Phe residue. This model implies that Site II could be the
actual substrate-binding site for PO activities. The PPO
activation process involves a movement of a flexible loop
at the entrance to the substrate binding Site II. This con-
formation change could be induced by the interaction of
PPO with other molecules. In vitro, the binding of ionic
detergents to the charged surface of PPO could induce
allosteric conformational changes at the loop Y230-P235.
In vivo, the mechanism of PPO activation is not yet well
understood, but our data presented here suggest that a
similar activation mechanism could also be adopted. The
opening of the gate at Site II could be modulated by ex-
quisite protein–protein interactions between PPO and the
activating protein complexes, which have been extensively
investigated in the prior studies [47, 62–65]. It is possible
that the proteolytic cleavage of PPO in the pro-region
could simply create surface complementarities between
these proteins for optimal binding and recruitment [26].
The ‘placeholder’ Phe residue therefore may not be dis-
lodged from its original stable position during this PPO
activation process.
Conclusions
In this work, we determined the crystal structure of a
recombinant PPO8 from a mosquito species, Anopheles
gambiae, which forms a homodimer with each subunit
containing a conserved type III di-copper active site. We
identified E364 as the catalytic residue key to the PO
activities through mutagenesis and functional analysis,
which elucidated a conserved catalytic mechanism
applicable to other type III di-copper enzymes. Our
results also revealed the actual substrate-binding site
and offered a novel model for PPO activation without
withdrawing the previously proposed ‘placeholder’ phenyl-
alanine residue. The data we presented here provides new
insights into the mechanisms of PPO activation and
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enzymatic catalysis, and should provide an important
focus for future investigations.
Methods
Plasmid construction, protein expression, purification and
crystallization
The DNA of the 5’ and 3’ AgPPO8 cDNA fragments
were amplified from a cDNA pool of second instar A.
gambiae larvae. The PCR products were separately
ligated with pGEM-T DNA (Promega) for transforming
JM109 (Promega). After sequence verification, the 5’ and
3’ fragments were retrieved and ligated with a modified
pET vector as a SUMO fusion with an N-terminal
6xHis-tag. There are two additional FLAG and c-Myc
tags next to the N-terminal and C-terminal of AgPPO8
sequence, respectively, which are used for functional
studies other than this work. Protein expression was car-
ried out in E. coli BL21 gold (DE3) cells (Stratagene).
The colony carrying the recombinant plasmid was
grown in LB medium and protein expression was
induced by 0.5 mM isopropyl-β-D-thiogalactopyranoside
at 16 °C for 16 h. The point mutation of AgPPO8 was
constructed following the protocol of QuikChange II
Site-Directed Mutagenesis Kit (Agilent Technologies,
Inc.). The AgPPO8 mutant was expressed in the same
way as the wild type protein. The individual proteins
were purified using a similar double Ni-nitrilotriacetic
acid procedure as previously described [66]. The purified
AgPPO8 was concentrated to 7.2 mg/mL. For optimal
reproducibility of crystallization, all purified proteins were
flash frozen and stored at −80 °C until usage [67].
AgPPO8 crystallized in sitting drops at room temperature
with a reservoir solution containing 0.2 M lithium citrate
tribasic tetrahydrate, 20 % PEG 3,350, at pH 8.4. Crystals
were cryoprotected by soaking in mother crystallization
solution containing 20 % glycerol.
Data collection and structural determination
A set of data was collected at 100 K to 2.60 Å resolution
at the Advanced Photon Source, beam-line 19-ID,
Argonne National Laboratory (Argonne, IL) and proc-
essed by the HKL3000 program [68]. The initial phasing
was obtained by molecular replacement with the Phaser
program of CCP4 suit, in which chain B of the crystal
structure of MsPPOs (PDB code 3HHS) was used as the
searching model. Subsequent model building was carried
out by Autobuild program of Phenix [69] coupled with
manual modeling using WinCoot [70]. The structure
was further refined using Phenix.refine and the final
model was analyzed by the Molprobity server [71]. The
current model is of excellent geometry and refinement
statistics (Table 1), and validated by wwpdb validation
servers [72]. The structure factors and atomic coordinates
for AgPPO8 have been deposited in the protein data bank
with accession code 4YZW. All structural figures were
generated using PyMol [73].
Fig. 5 A loop gating model for AgPPO8 activation. (a) The top view of Site II pocket with docked tyramine (green) and dopamine (yellow). The
secondary structures of AgPPO8 are shown in gray. The flexible loop Y230-P235 (red) forms loose van der Waals contacts with the α-helix P101-D116 (red),
controlling the entrance to the substrate binding Site II (cyan). The putative placeholder F99 and the catalytic residue E364 are shown as violet sticks. Inset
shows the sequence alignment of the loop among different PPOs from insects and crustaceans. Ms, Manduca sexta; Dm, Drosophila melanogaster; Ag,
Anopheles gambiae; Aa, Aedes aegypti; Tm, Tenebrio molitor; Bm, Bombyx mori; Mr, Macrobrachium rosenbergii; Pt, Portunus trituberculatus; Mj, Marsupenaeus
japonicas. The distances from E364 to the putative placeholder F99 (magenta) and the docked tyramine (green)/dopamine (yellow) are indicated.
(b) A cartoon illustration of the loop gated AgPPO8 activation. The side view of the Site II pocket is shown with the loop-helix controlled entrance located
at the top. Left, closed state. Right, open state. Conformational changes at the molecular surface disrupt the loose contact between the loop Y230-P235
and the helix P101-D116, opening the gate and allowing the substrates to access the active site
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UV/vis absorption spectrophotometry
Beckman DU520 General Purpose UV/vis Spectropho-
tometer was used for recording the UV/vis absorption
spectrum of AgPPO8. A quartz micro cell cuvette of
1 cm path length was used. AgPPO8 protein was diluted
to 0.5 mg/mL, with a buffer of 20 mM Tris–HCl and
500 mM NaCl, at pH 7.8. The absorption spectrum scan
was recorded from 250–700 nm.
Dynamic light scattering of AgPPO8
The protein sample (7.2 mg/mL) in 20 mM Tris–HCl
and 500 mM NaCl, at pH 7.8 was added into the
ZMV1002 quartz batch cuvette and particle size was
measured by using dynamic light scattering in the dual
capability Zetasizer μV (Malvern, Inc.).
Docking analysis
The docking of tyrosine or dopamine into the AgPPO8
active site was performed using AutoDock (version
4.2.6) [74]. The structures of tyramine and dopamine
were obtained from Protein Database Bank. Based on
the analysis from the previously published structures,
H223, 227, 252, 379, 383, 419, L98, F99, F248, F415,
E364, N380, and V406 were selected as flexible residues,
and all of the bonds between CuA and CuB, except for
that of V406, were inactivated, to allow slight protein
dynamics upon substrate binding. Lamarckian genetic
algorithm with 2,500,000 evaluations per run was chosen
as the searching method. Default settings were used for
all other docking parameters. The copper parameters
were set as r (van der Waal’s radii) = 3.50, ε (vdW well
depth) = 0.005 kcal/mol, and a charge of +2.0e. The
docked conformation with the lowest docked energy and
correct orientation (with the phenol groups of the sub-
strate pointing towards the dicopper site) was selected
for binding analysis.
Enzyme activity assay
Enzymatic activities were measured by a microplate
assay as previously described [57]. For determination of
diphenol oxidase activity, 0.5 μg PPO, 50 μM CuCl2 and
0.002 % (w/v) CPC were mixed in the buffer of 20 mM
Tris–HCl at pH 7.5, bringing a final volume to 15 μL.
The mixture was incubated at room temperature for
10 min, followed by addition of 150 μL of 2 mM dopa-
mine dissolved in 50 mM MOPS buffer at pH 6.5. The
absorbance at 470 nm was monitored on a plate reader
(Molecular Device VersaMax). One unit of PO activity
was defined as the amount of activated PPO causing the
increase of 0.001 absorbance unit per min. For hydroxy-
lase activity measurement, 5 μg AgPPO8 was incubated
with 50 μM CuCl2 and 0.02 % (w/v) CPC in the same
way and 150 μL of 2 mM tyramine was used as the sub-
strate. Dopamine formation was detected as the increase
of absorbance at 280 nm [75]. Note that the absorbance
increase at 280 nm includes a small contribution from the
further dopamine–dopamine quinone conversion cata-
lyzed by CPC-activated PPO. For each reaction, three rep-
licates were performed and specific activity (U/μg) was
presented as mean ± SEM.
Differential scanning fluorimetry
AgPPO8 wild type and E364Q mutant proteins were
purified in the buffer containing 100 mM HEPES and
150 mM NaCl, at pH 7.5; 40 μL of the protein at
0.3 mg/mL concentration were mixed with 0.8 μL of
100× SYPRO-Orange fluorescence dye (Invitrogen) to
bring to a final 2× concentration. Thermal denaturation
curves were monitored on Bio-Rad CFX Connect Real-
time PCR Detection System, with a thermal gradient of
0.5 °C increment per 30 seconds from 24–95 °C (excita-
tion wavelength at 515–535 nm, emission wavelength at
560–580 nm). For each reaction, three replicates were
performed, and the Tm value was calculated using the
CFX manager software v3.1 (Bio-Rad Laboratories, Inc.).
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Completeness, % 99.0 (97.3)
I/σ 8.9 (1.8)
Rsym, % 12.9 (47.2)
Refinement statistics
Reflection range used, Å 2.60–44.32
No. reflections used 42,950
Rwork/Rfree, % 18.8/23.3
rmsd bonds, Å 0.0046








Rsym = ∑|Iobs - Iavg|/ ∑ Iavg; Rwork = ∑ ││Fobs – Fcalc││/ ∑ Fobs
Rfree was calculated using 5 % data
APS, Advanced Photon Source; I/σ, Intensity/Sigma (Intensity). Values in
parentheses are for the highest-resolution shell 2.69–2.60 Å
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Availability of supporting data
The atomic coordinates and structure factors of AgPPO8
have been deposited in the Protein Data Bank, www.
rcsb.org (PDB accession code 4YZW).
Additional files
Additional file 1: AgPPO8 exists as a homodimer in solution.
(A) AgPPO8 appears as dimeric on size exclusion chromatography (SEC).
The theoretical molecular weight (MW) of AgPPO8 monomer is 81 kDa,
calculated by ExPASy server (http://web.expasy.org/compute_pi/). The
retention volumes are aligned between the standard proteins (Upper
panel) and AgPPO8 (Lower panel). Standards: thyroglobulin (bovine),
670 kDa; γ-globulin (bovine), 158 kDa; ovalbumin (chicken), 44 kDa;
myoglobin (horse), 17 kDa; vitamin B12, 1.35 kDa. AgPPO8 was eluted out
at a similar retention volume as that of γ-globulin (bovine). The calculated
MW of AgPPO8 from the chromatograph is 142 kDa, indicating a dimer.
(B) AgPPO8 displays as dimeric from dynamic light scattering. AgPPO8 at
a concentration of 1.5 mg/mL was used in the experiment. AgPPO8 displays
as monodisperse in solution with a MW of 165.9 ± 30.5 kDa, corresponding
to a dimer and consistent with the result from SEC analysis. (TIF 1376 kb)
Additional file 2: The electron density map at the di-nuclear active
site of AgPPO8. The electron densities of 2Fo-Fc map and Fo-Fc difference
map are contoured at the sigma level of 1.0 and 3.0, and shown as gray
and green mesh, respectively. (TIF 3813 kb)
Additional file 3: The six Cu-coordinating His residues are stabilized
by three Phe residues at the active site of AgPPO8 via hydrophobic
interactions. The six His and three Phe residues are shown as magenta
and red sticks, respectively. The shortest carbon-carbon distances (Å) are
indicated as black (F99), yellow (F248), and green (F415) dashes, respectively.
CuA and CuB are shown as brown spheres. (TIF 3116 kb)
Additional file 4: UV/Vis absorption spectrum of AgPPO8. The purified
AgPPO8 (0.5 mg/mL) was used for absorbance scanning from 250 to
700 nm. A sharp peak at 280 nm was observed for the protein and no
obvious absorbance peak was detected at other wavelength. (TIF 270 kb)
Additional file 5: Docking of substrates to the Site II pocket of
AgPPO8. (A) The binding energy for each individually docked
conformation of tyramine/dopamine is ranked and listed in the table. (B)
Superposition of all docked conformations with the correct orientations
of tyramine (left) and dopamine (right). The best models of the bound
substrates with the lowest binding energies are shown as yellow sticks,
with all the other docking modes shown in lines. (TIF 799 kb)
Additional file 6: Characterization of the purified AgPPO8 wild type
(WT) and E364Q mutant proteins. (A) SDS-PAGE analysis of the purified
AgPPO8 WT and E364Q mutant under reducing and non-reducing conditions.
(B) Thermal denaturation (Tm) values (°C) of AgPPO8 WT and E364Q mutant.
All data were presented as mean ± SD (n = 3). (TIF 623 kb)
Additional file 7: Docking analysis of phenolic substrates into the
F99-deleted AgPPO8 active site. The docked active site structures, with
(magenta) or without (silver) the putative placeholder F99, are superimposed.
(A) tyramine, (B) dopamine. The docked substrates in the active site are shown
as yellow in F99-containing and green in the absence of F99, respectively. The
envelope of Site II pocket is delineated in cyan, while CuA and CuB are shown
as brown spheres. All the docking parameters were the same with the only
difference being the presence or absence of F99. The best models with the
lowest binding energy and correct orientation were selected for analysis.
(TIF 1513 kb)
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